Stock Events

Stock Events

Can-Fite Biopharma (CANF) Q3 2024 Earnings

29AugConfirmed

Q4 2022

Q1 2023

Q2 2024

Q3 2024

-0.19

-0.13

-0.06

0

Details

Expected EPS

-0.000366

Actual EPS

-0.001099

Surprise EPS

-0

Surprise Percent

+200.27%

Description

Can-Fite Biopharma (CANF) has reported earnings of -0.001099 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.